events
Mark your calendar for November 19-21 and meet us at Fi Europe 2024, Messe Frankfurt, Germany. We look forward to connecting with you at this exciting event!
Learn More >>
Services

Professional and Cost-Saving Solutions

Services
Online Inquiry

Our Products Cannot Be Used As Medicines Directly For Personal Use.

24 hour
Promise

Welcome! For price inquiries, please feel free to contact us through the form on the left side. We will get back to you as soon as possible.

Relieving Hypoxia in Tumors with Nanozymes

Solid tumors consist of cancer cells and their living environment, also termed tumor microenvironment (TME). There are many differences between TME and the normal human environment, among which the biggest difference is the high amount of H2O2, hypoxia and low pH. Because of these characteristics, a large number of cell growth factors, chemokines and hydrolases exist in the TME, causing inflammatory reactions, promoting the rapid proliferation of tumor cells, and making tumor tissues resistant to radiotherapy and chemotherapy.

Previously, traditional cancer therapy avenues were mostly focused on cancer cells. Recently, more and more lines of evidence have shown that TME is also critical to malignant tumor behaviors. Creative Enzymes provides a variety of enzymes for treatment of tumors by relieving hypoxia.

Pt Nanozymes in Tumors Treatment via Relieving Hypoxia

  • Through the CAT activity of nanozyme, H2O2 can be catalyzed to O2, which can alleviate hypoxia in tumor tissues and promote apoptosis of tumor cells. It also cooperates with other light, sound and chemo dynamic therapies for tumor treatment.
  • Creative Enzymes modifies Pt nanozymes with essential catalase activity, which can effectively decompose H2O2 accumulated in tumors to produce O2 and alleviate tumor hypoxia. The generated O2 can improve photodynamic anti-tumor activity, and the generated 1O2 can lead to the apoptosis of tumor cells.
  • In addition, Pt nanozymes reduce the risk of tumor treatment by regulating the hypoxic environment and downregulating the expression of HIF-1α protein.

BiO2−X Nanozymes in Tumors Treatment via Relieving Hypoxia

  • We also synthesize BiO2−X nanozymes with catalase activity.

BiO2–x nanozymes with catalase-like activity for hypoxia alleviation of tumors. - Creative Enzymes Fig. 1 BiO2–x nanozymes with catalase-like activity for hypoxia alleviation of tumors.

  • Catalase activity can decompose the highly expressed H2O2 into O2 at the tumor site, to alleviate tumor hypoxia. Besides, it can down-regulate the expression of HIF-1α, thus enhancing the therapeutic effect of radiotherapy.

CeO2 Nanozymes in Tumors Treatment via Relieving Hypoxia

We synthesize a novel CeO2 nanozyme that shows superior peroxidase activity and decomposes H2O2 into O2. It can significantly alleviate tumor hypoxia, induce DNA damage, and achieve tumor treatment.

MnO2 Nanozymes in Tumors Treatment via Relieving Hypoxia

  • The modified MnO2 nanozymes we synthesize and design have been found to have excellent catalase activity.
  • They can generate O2 by consuming endogenous H2O2, overcome tumor hypoxia and enhance photodynamic therapy to achieve esophageal cancer treatment.

Creative Enzymes has been dedicated to nanozymes research for many years. We will complete your studies on time and on budget. We guarantee the confidentiality and sensitivity of our customers' data. If you are interested in our services or have any questions, please feel free to contact us or make an online inquiry.

Our Products Cannot Be Used As Medicines Directly For Personal Use.